Meanwhile, Leerink Partners downgraded its Affimed N.V [AFMD] rating to a Market perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. Stifel also remained covering AFMD and has decreased its forecast on October 10, 2022 with a “Hold” recommendation from previously “Buy” rating.
Price Performance Review of AFMD
On Tuesday, Affimed N.V [NASDAQ:AFMD] saw its stock fall -80.66% to $0.13. Over the last five days, the stock has lost -83.04%. Affimed N.V shares have fallen nearly -88.74% since the year began. Nevertheless, the stocks have fallen -97.44% over the past one year. While a 52-week high of $8.95 was reached on 01/02/25, a 52-week low of $0.52 was recorded on 05/13/25. SMA at 50 days reached $0.8002, while 200 days put it at $2.2563.
Levels Of Support And Resistance For AFMD Stock
The 24-hour chart illustrates a support level at 0.1171, which if violated will result in even more drops to 0.1002. On the upside, there is a resistance level at 0.1638. A further resistance level may holdings at 0.1936. The Relative Strength Index (RSI) on the 14-day chart is 21.11, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.3074, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.60%. Stochastics %K at 1.61% indicates the stock is a buying.
The most recent change occurred on March 31, 2022 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $7 price target.
